Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA name
hsa-miR-98
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
LASS2
Cancer name
Bladder Cancer
Cancer site
Bladder
Treatment type
Chemotherapy
Drug
Cisplatin/Doxorubicin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Up
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
LASS2 and regulates bladder cancer chemoresistance through modulation of mitochondrial function.
Tissue resource
fresh samples from bladder urothelial carcinoma and corresponding normal adjacent tissues
bladder cancer cell lines SV-HUC-1
bladder cancer cell lines J82
bladder cancer cell lines T24
bladder cancer cell lines 5637
bladder cancer cell lines RT4
Experiment
qRT-PCR,Western blot
Institute
the Second Affiliated Hospital of Kunming Medical University
American Type Culture Collection
Country
China
USA
Continent
Asia
North American
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.